The story of Sildenafil offers a complicated case study for stakeholders eyeing pharma. While first sales were explosive, recent patent expiry and the emergence of cheaper versions have severely impacted earnings. https://mathetidr849584.thekatyblog.com/39235399/viagra-and-the-pharmaceutical-industry-a-dangerous-stake